Mark Bye

Background

Mark Bye is an Operating Partner of Morgan Stanley Capital Partners (MSCP) and is based in New York. Mr. Bye joined Morgan Stanley in 2008 and was previously President and CEO of Dystar, GmBH, a specialty chemicals company providing dyes, pigments, and services to the textile, paper and plastics industries.

Prior to Dystar, Mr. Bye spent 23 years at Air Products and Chemicals (NYSE: APD) where he held a number of executive positions including Group Vice President of the Gases & Equipment Group, President of Air Products Asia and Vice President/General Manager of the Performance Chemicals Division. Prior to this he spent three years at Union Carbide Corp. Mr. Bye serves on the board of directors for Carus Chemical Corporation, Sterling Energy, PPC Flexible Packaging, Comar, and M.G. Bryan, XRI and Specialized Desanders, all Morgan Stanley Energy Partners (MSEP) portfolio companies. He was previously on the board of directors of McKechnie Aerospace, Breitenfeld AG and Trinity CO2 and is active in the American Institute of Chemical Engineers.

Mr. Bye holds a B.S. and an M.S. from the Massachusetts Institute of Technology.

The information on this page is for informational purposes only. It is intended for the benefit of third party issuers and those seeking information about alternatives investment strategies. The information contained herein does not constitute and should not be construed as an offering of advisory services or an offer to sell or a solicitation of an offer to buy any securities in any jurisdiction in which such offer or solicitation, purchase or sale would be unlawful under the securities, insurance or other laws of such jurisdiction.

All investing involves risks, including a loss of principal. Alternative investments are speculative and involve a high degree of risk. These investments are designed for investors who understand and are willing to accept these risks. Performance may be volatile, and an investor could lose all or a substantial portion of his or her investment.

Please refer to the strategy detail page for important information on the strategy, including additional risk considerations.

It is important that users read the Terms of Use before proceeding as it explains certain legal and regulatory restrictions applicable to the dissemination of information pertaining to Morgan Stanley Investment Management's investment products.

The services described on this website may not be available in all jurisdictions or to all persons. For further details, please see our Terms of Use.